These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 2863440)

  • 21. [The effect of pirenzepine (LS 519) on basal and pentagastrin-stimulated gastric acid secretion in normal persons].
    Galmiche JP; Lerebours E; Colin R
    Med Chir Dig; 1980; 9(4):331-4. PubMed ID: 6894012
    [No Abstract]   [Full Text] [Related]  

  • 22. Antisecretory and antiulcer activities of a potent new histamine H2-receptor antagonist with an intermediate duration of action.
    Borella L; Russell J; Rimele TJ; Grimes D; Failli A; Mir GN
    Arzneimittelforschung; 1988 Mar; 38(3):366-72. PubMed ID: 2898247
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of two doses of pirenzepine on histamine-stimulated gastric acid secretion in man.
    Eugenides N; Stockbrügger RW; Hobsley M; Cotton PB
    Scand J Gastroenterol Suppl; 1982; 72():125-9. PubMed ID: 6957980
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of secretagogue selection on potency determinations for gastric acid antisecretory agents.
    Palumbo GJ; Nielsen ST
    Methods Find Exp Clin Pharmacol; 1988 Mar; 10(3):151-5. PubMed ID: 2898575
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effects of acid inhibitors on gastric mucus.
    Guslandi M
    Aliment Pharmacol Ther; 1996 Aug; 10(4):669-70. PubMed ID: 8853775
    [No Abstract]   [Full Text] [Related]  

  • 26. Structural modification of H2-receptor antagonists provide post-H2-receptor gastric antisecretory activity.
    Nielsen ST; Dove PA; Strike DP; Schiehser GA
    Drugs Exp Clin Res; 1987; 13(5):297-304. PubMed ID: 2890506
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A review of the animal pharmacology of ranitidine--a new, selective histamine H2-antagonist.
    Brittain RT; Daly MJ
    Scand J Gastroenterol Suppl; 1981 Jun; 69():1-9. PubMed ID: 6119770
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Non-antisecretory activities of H2 antagonists.
    Bertaccini G; Coruzzi G
    Scand J Gastroenterol Suppl; 1986; 121():30-6. PubMed ID: 2876512
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of the H2 receptor antagonist and gastric acid antisecretory properties of Wy-45,727.
    Nielsen ST
    J Pharmacol Exp Ther; 1987 Aug; 242(2):607-13. PubMed ID: 2886646
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antisecretory effects of two new histamine H2-receptor antagonists.
    Bickel M; Herling AW; Rising TJ; Wirth K
    Arzneimittelforschung; 1986 Sep; 36(9):1358-63. PubMed ID: 2878669
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of histamine H2-receptor antagonists on blood flow and secretion of the resting and stimulated stomach.
    Varró V; Döbrönte Z; Sági I
    Mater Med Pol; 1981; 13(1):3-6. PubMed ID: 6119401
    [No Abstract]   [Full Text] [Related]  

  • 32. Suppression of gastric acidity in horses.
    Murray MJ
    J Am Vet Med Assoc; 1997 Jul; 211(1):37-40. PubMed ID: 9215408
    [No Abstract]   [Full Text] [Related]  

  • 33. [Gastric acid secretion inhibitors: H2 receptor antagonists (H2RA), proton pump inhibitors (PPI) or acid pump antagonists (APA)].
    Mazure PA
    Acta Gastroenterol Latinoam; 1996; 26(4):263-5. PubMed ID: 9335935
    [No Abstract]   [Full Text] [Related]  

  • 34. Effect of H2 receptor- and muscarine receptor antagonists and prostaglandin E1 analog on the gastric mucosal hemodynamics and oxygen sufficiency in rats.
    Sato N; Quan LH; Kawano S; Kamada T; Abe H
    Adv Exp Med Biol; 1984; 180():763-71. PubMed ID: 6152515
    [No Abstract]   [Full Text] [Related]  

  • 35. Prevention and treatment of non-steroidal anti-inflammatory drug-induced gastro-duodenal damage: rationale for the use of antisecretory compounds.
    Scarpignato C; Pelosini I
    Ital J Gastroenterol Hepatol; 1999; 31 Suppl 1():S63-72. PubMed ID: 10379472
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Second-generation histamine H(2)-receptor antagonists with gastric mucosal defensive properties.
    Ichikawa T; Hotta K; Ishihara K
    Mini Rev Med Chem; 2009 May; 9(5):581-9. PubMed ID: 19456288
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Several new inhibitors of gastric secretion].
    Vasilevskaia LS
    Fiziol Zh SSSR Im I M Sechenova; 1978 Jun; 64(6):871-5. PubMed ID: 28254
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [SKF 93479, a newly developed histamine H2-receptor antagonist. / Effect on gastric potential difference in the presence and absence of acetylsalicylic acid].
    Müller P; Dammann HG; Kessler R; Simon B
    Arzneimittelforschung; 1982; 32(8):840-1. PubMed ID: 6128005
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cytoprotection by PGE2, pirenzepine or vagotomy: a transmission and scanning electron microscopic study in rats.
    Trabucchi E; Foschi D; Colombo R; Baratti C; Del Soldato P; Centemero A; Rizzitelli E; Montorsi W
    Pharmacol Res Commun; 1986 Apr; 18(4):357-69. PubMed ID: 3461488
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gastrointestinal drug receptors.
    Burks TF; Galligan JJ; Porreca F
    J Clin Gastroenterol; 1983; 5 Suppl 1():29-36. PubMed ID: 6140283
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.